381 related articles for article (PubMed ID: 34763233)
1. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
2. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma.
Li D; Liu Y; Hao S; Chen B; Li A
J Clin Lab Anal; 2020 Dec; 34(12):e23537. PubMed ID: 32860274
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
[TBL] [Abstract][Full Text] [Related]
4. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients.
Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K
BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744
[TBL] [Abstract][Full Text] [Related]
5. Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer.
Tan XF; Chen Q; Hua SH; Yip GW
Curr Med Chem; 2021; 28(25):5034-5047. PubMed ID: 34139972
[TBL] [Abstract][Full Text] [Related]
6. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
7. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
[TBL] [Abstract][Full Text] [Related]
8. The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.
Zhang W; Xie X; Huang Z; Zhong X; Liu Y; Cheong KL; Zhou J; Tang S
Front Immunol; 2022; 13():919145. PubMed ID: 36211371
[TBL] [Abstract][Full Text] [Related]
9. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G; Yan J
Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
[TBL] [Abstract][Full Text] [Related]
12. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
[TBL] [Abstract][Full Text] [Related]
13. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
14. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
[TBL] [Abstract][Full Text] [Related]
16. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
Lin W; Tan ZY; Fang XC
SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
[TBL] [Abstract][Full Text] [Related]
17. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
18. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
19. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract][Full Text] [Related]
20. Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients.
Si Z; Hu H
Med Sci Monit; 2021 Jul; 27():e932052. PubMed ID: 34247183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
